AU4668193A - Method of treating ophthalmic disorders using tgf-beta - Google Patents

Method of treating ophthalmic disorders using tgf-beta

Info

Publication number
AU4668193A
AU4668193A AU46681/93A AU4668193A AU4668193A AU 4668193 A AU4668193 A AU 4668193A AU 46681/93 A AU46681/93 A AU 46681/93A AU 4668193 A AU4668193 A AU 4668193A AU 4668193 A AU4668193 A AU 4668193A
Authority
AU
Australia
Prior art keywords
tgf
beta
ophthalmic disorders
treating ophthalmic
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU46681/93A
Inventor
Bert M. Glaser
Ann F Hanham
George A. Ksander
Bruce B. Pharriss
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Celtrix Pharmaceuticals Inc
Original Assignee
Celtrix Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celtrix Pharmaceuticals Inc filed Critical Celtrix Pharmaceuticals Inc
Publication of AU4668193A publication Critical patent/AU4668193A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1841—Transforming growth factor [TGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
AU46681/93A 1992-07-08 1993-07-08 Method of treating ophthalmic disorders using tgf-beta Abandoned AU4668193A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US91083492A 1992-07-08 1992-07-08
US910834 1992-07-08
US877893A 1993-01-22 1993-01-22
US008778 1993-01-22
PCT/US1993/006420 WO1994001124A1 (en) 1992-07-08 1993-07-08 METHOD OF TREATING OPHTHALMIC DISORDERS USING TGF-$g(b)

Publications (1)

Publication Number Publication Date
AU4668193A true AU4668193A (en) 1994-01-31

Family

ID=26678611

Family Applications (1)

Application Number Title Priority Date Filing Date
AU46681/93A Abandoned AU4668193A (en) 1992-07-08 1993-07-08 Method of treating ophthalmic disorders using tgf-beta

Country Status (5)

Country Link
EP (1) EP0651650A4 (en)
JP (1) JPH08502033A (en)
AU (1) AU4668193A (en)
CA (1) CA2138644A1 (en)
WO (1) WO1994001124A1 (en)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5688765A (en) * 1992-04-21 1997-11-18 The Schepens Eye Research Institute, Inc. Ocular therapy in Sjogren's syndrome using topically applied androgensor TGF-β
WO1995009003A1 (en) * 1993-09-29 1995-04-06 Alcon Laboratories, Inc. Compositions containing growth factors and antimetabolites
WO1995009004A1 (en) * 1993-09-29 1995-04-06 Alcon Laboratories, Inc. Compositions containing growth factors and antiplastic agents
US5449671A (en) * 1993-09-29 1995-09-12 Alcon Laboratories, Inc. Use of TGF-β3, to prevent or retard fistula closure following glaucoma filtration surgery
US5411940A (en) * 1993-09-29 1995-05-02 Alcon Laboratories, Inc. Use of TGF-β3 to reduce the formation of scar tissue in response to corneal trauma
ATE315939T1 (en) * 1993-11-19 2006-02-15 Univ Sydney METHOD FOR PROPHYLAXIS OR CONTROL OF CATARACT
AU688409B2 (en) * 1993-11-19 1998-03-12 University Of Sydney, The A method for preventing or controlling cataract
WO2001009327A2 (en) * 1999-07-28 2001-02-08 Genentech, Inc. Method of preventing the injury or death of retinal cells and treating ocular diseases
US5827702A (en) * 1994-10-31 1998-10-27 Genentech, Inc. Ocular gene therapy
WO1998024468A1 (en) * 1996-12-04 1998-06-11 Clark Abbot F TGFα FOR THE TREATMENT OF OCULAR HYPERTENSION AND GLAUCOMA
AU8656098A (en) * 1997-07-23 1999-02-16 Brigham And Women's Hospital Lens epithelial cell derived growth factor
US6750052B1 (en) 1997-07-23 2004-06-15 The Brigham And Women's Hospital, Inc. Lens epithelial cell derived growth factor
US6331523B1 (en) 1998-03-12 2001-12-18 Genentech, Inc. Method of enhancing the survival of retinal neurons and treating ocular diseases using FGF-5
NZ511559A (en) * 1998-11-23 2004-01-30 Novartis Ag Use of staurosporine derivatives for treating ocular neovascular diseases
AU3737500A (en) * 1999-03-12 2000-09-28 Genentech Inc. Method of preventing the death of retinal neurons and treating ocular diseases
AU2001228863A1 (en) * 2000-01-31 2001-08-14 Santen Pharmaceutical Co. Ltd. Remedies for ophthalmic diseases
US20070202186A1 (en) 2006-02-22 2007-08-30 Iscience Interventional Corporation Apparatus and formulations for suprachoroidal drug delivery
US8197435B2 (en) 2006-05-02 2012-06-12 Emory University Methods and devices for drug delivery to ocular tissue using microneedle
KR20150083117A (en) 2012-11-08 2015-07-16 클리어사이드 바이오메디컬, 인코포레이드 Methods and devices for the treatment of ocular disease in human subjects
CN110302004B (en) 2013-05-03 2023-04-28 科尼尔赛德生物医学公司 Apparatus and method for ocular injection
RU2540504C1 (en) * 2013-12-26 2015-02-10 Федеральное государственное бюджетное учреждение "Московский научно-исследовательский институт глазных болезней имени Гельмгольца" Министерства здравоохранения Российской Федерации Method for prediction of risk of late retinal detachment in children with cicatrical retinopathy of prematurity
US20170080030A1 (en) * 2014-03-17 2017-03-23 University Of Virginia Patent Foundation Compositions and methods for treating retinopathy
US9844556B2 (en) 2015-03-25 2017-12-19 Megumi Honjo Preventive/therapeutic method and preventive/therapeutic agent for complications after cataract surgery
EP3413851B1 (en) 2016-02-10 2023-09-27 Clearside Biomedical, Inc. Packaging
CA3062845A1 (en) 2016-05-02 2017-11-09 Clearside Biomedical, Inc. Systems and methods for ocular drug delivery
US10973681B2 (en) 2016-08-12 2021-04-13 Clearside Biomedical, Inc. Devices and methods for adjusting the insertion depth of a needle for medicament delivery
CN111803623A (en) * 2020-07-31 2020-10-23 重庆康视美科技有限公司 Biological preparation for treating myopia and preparation method and use method thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8532691A (en) * 1990-08-01 1992-03-02 Chiron Ophthalmics Inc. Method for treating corneal endothelial wounds

Also Published As

Publication number Publication date
EP0651650A1 (en) 1995-05-10
WO1994001124A1 (en) 1994-01-20
CA2138644A1 (en) 1994-01-20
JPH08502033A (en) 1996-03-05
EP0651650A4 (en) 1996-04-17

Similar Documents

Publication Publication Date Title
AU4668193A (en) Method of treating ophthalmic disorders using tgf-beta
AU5540594A (en) Method of performing ophthalmic surgery
AU1436595A (en) Method of treatment of traumatic brain injury
AU6515794A (en) Cornea operating method and apparatus
AU5163193A (en) Method and apparatus for corneal reprofiling
AU7545594A (en) Implantable device for the treatment of aedemas
AU7516994A (en) Method and device for treating bone disorders
AUPM864894A0 (en) Treatment of bowel-dependent neurological disorders
AU4995693A (en) Apparatus and method for the treatment of blood
AU4918796A (en) Methods of treating or preventing psychiatric disorders
AU1173195A (en) Treatment of immunoregulatory disorders
AU1935395A (en) Method for treating conditions of the eye using polypeptides
AUPN271295A0 (en) Method of treatment
AU2103295A (en) Methods for the treatment of thrombosis
AU3155495A (en) Method of treating contact lenses
EP0729361A4 (en) Method of treating neurological disorders
AU3730093A (en) Methods of treating diabetes
AU6798490A (en) Ocular treatment apparatus
AU5713196A (en) Method for treatment of pain
AU4104093A (en) Method and compositions for treatment of pyonecrotic processes
AU6963596A (en) Method and composition for the manufactue of ophthalmic lenses
AU7113996A (en) Methods of treating beta-amyloid-associated conditions
AU636421B2 (en) Method for the treatment of glaucoma
AU3779595A (en) Method of treating turf
AU7349496A (en) Method for treatment of SLE